| NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives CL Nigro, M Macagno, D Sangiolo, L Bertolaccini, M Aglietta, MC Merlano Annals of translational medicine 7 (5), 2019 | 220 | 2019 |
| Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer S Lanzardo, L Conti, R Rooke, R Ruiu, N Accart, E Bolli, M Arigoni, ... Cancer research 76 (1), 62-72, 2016 | 112 | 2016 |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients G Crisafulli, A Sartore-Bianchi, L Lazzari, F Pietrantonio, A Amatu, ... Cancer Discovery 12 (7), 1656-1675, 2022 | 58 | 2022 |
| Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells L Gammaitoni, L Giraudo, M Macagno, V Leuci, G Mesiano, R Rotolo, ... Clinical Cancer Research 23 (9), 2277-2288, 2017 | 38 | 2017 |
| The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis S Bandini, M Macagno, A Hysi, S Lanzardo, L Conti, A Bello, F Riccardo, ... Oncoimmunology 5 (12), e1253653, 2016 | 35 | 2016 |
| Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice L Conti, R Ruiu, G Barutello, M Macagno, S Bandini, F Cavallo, ... BioMed research international 2014, 2014 | 35 | 2014 |
| Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice S Bandini, C Curcio, M Macagno, E Quaglino, M Arigoni, S Lanzardo, ... Oncoimmunology 2 (9), e26137, 2013 | 35 | 2013 |
| BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody M Sanlorenzo, I Vujic, A Floris, M Novelli, L Gammaitoni, L Giraudo, ... Clinical Cancer Research 24 (14), 3377-3385, 2018 | 32 | 2018 |
| Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination N Brasu, I Elia, V Russo, G Montacchiesi, SA Stabile, C De Intinis, F Fesi, ... Nature Immunology 23 (10), 1445-1456, 2022 | 29 | 2022 |
| Capecitabine and temozolomide versus FOLFIRI in RAS-mutated, MGMT-methylated metastatic colorectal cancer F Pietrantonio, R Lobefaro, M Antista, S Lonardi, A Raimondi, F Morano, ... Clinical Cancer Research 26 (5), 1017-1024, 2020 | 25 | 2020 |
| Chimeric DNA vaccines: an effective way to overcome immune tolerance F Riccardo, E Bolli, M Macagno, M Arigoni, F Cavallo, E Quaglino Cancer vaccines, 99-122, 2017 | 24 | 2017 |
| Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans E Quaglino, F Riccardo, M Macagno, S Bandini, R Cojoca, E Ercole, ... Cancers 3 (3), 3225-3241, 2011 | 23 | 2011 |
| A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model A Msaki, A Pastò, M Curtarello, M Arigoni, G Barutello, RA Calogero, ... Oncotarget 7 (22), 33081, 2016 | 18 | 2016 |
| The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway M Pergolizzi, L Bizzozero, F Maione, E Maldi, C Isella, M Macagno, ... Journal of Experimental & Clinical Cancer Research 41 (1), 266, 2022 | 17 | 2022 |
| Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice M Macagno, S Bandini, L Stramucci, E Quaglino, L Conti, E Balmas, ... The Journal of Immunology 192 (11), 5434-5441, 2014 | 17 | 2014 |
| Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation F Orzan, F De Bacco, E Lazzarini, G Crisafulli, A Gasparini, A Dipasquale, ... Clinical Cancer Research 29 (7), 1252-1266, 2023 | 16 | 2023 |
| Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients C Nicolazzo, L Barault, S Caponnetto, M Macagno, G De Renzi, ... Cancers 12 (12), 3633, 2020 | 12 | 2020 |
| True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature C Nicolazzo, L Barault, S Caponnetto, G De Renzi, F Belardinilli, I Bottillo, ... Cancer Letters 507, 89-96, 2021 | 10 | 2021 |
| Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis M Macagno, S Bandini, E Bolli, A Bello, F Riccardo, G Barutello, ... Biomedicines 10 (2), 230, 2022 | 2 | 2022 |
| Indoleamine 2, 3-Dioxygenase (IDO) silencing for improved antitumour vaccination M Macagno, E Bolli, C Marchini, A Amici, C Riganti, A Bosia, G Forni, ... European Journal of Cancer 8 (5), 75-75, 2010 | 2 | 2010 |
